39 results
424B5
MSD Netherlands Capital B.V.
15 May 24
Prospectus supplement for primary offering
4:07pm
a distribution of Organon’s publicly traded stock to our shareholders. The established brands included in the transaction consisted of dermatology, non-opioid … consisted of dermatology, non-opioid pain management, respiratory, select cardiovascular products, as well as the rest of our diversified brands
POSASR
MSD Netherlands Capital B.V.
15 May 24
Automatic shelf registration (post-effective amendment)
11:31am
brands included in the transaction consisted of dermatology, non-opioid pain management, respiratory, select cardiovascular products, as well
S-3ASR
MRK
Merck & Co Inc
19 Mar 24
Automatic shelf registration
4:28pm
of Organon’s publicly traded stock to our shareholders. The established brands included in the transaction consisted of dermatology, non-opioid pain
S-3ASR
MRK
Merck & Co Inc
19 Mar 24
Automatic shelf registration
4:26pm
of Organon’s publicly traded stock to our shareholders. The established brands included in the transaction consisted of dermatology, non-opioid pain
424B5
gmsjd bo8fz
10 May 23
Prospectus supplement for primary offering
4:27pm
424B5
rxlxb
8 May 23
Prospectus supplement for primary offering
8:17am
SD
EX-1.01
bexzib2osc87px fb
20 May 22
Conflict minerals disclosure
4:06pm
424B5
5tlm66ju p4aw
9 Dec 21
Prospectus supplement for primary offering
4:37pm
424B5
12zo3a aehkyujzkd
7 Dec 21
Prospectus supplement for primary offering
8:13am
PX14A6G
i58cfpf2yo85 3z37h
6 May 21
Letter to shareholders
3:11pm
S-3ASR
gx9 c17yg5i6
25 Mar 21
Automatic shelf registration
4:46pm
S-3ASR
kqnrwv
25 Mar 21
Automatic shelf registration
4:42pm